Specifically, our analyses revealed that the KRAS-G12D mutation rewires Met and Arg metabolism in B-ALL cells, causing increased Met and Arg catabolism that is accompanied by increased anabolism of polyamines and proline, respectively. The gene discussed is KRAS; the disease is acute lymphoblastic leukemia.